Back to Directory
Stemnovate
East of England
Founded 2016
Ethically-sourced iPS cell biobank and stem cell drug discovery platform
Stemnovate is a Cambridge biotechnology company using stem cell models and tissue engineering to reduce reliance on animal testing.
The company operates a commercial biobank of human induced pluripotent stem cells with complete genotype information, addressing gender diversity gaps in cell research, alongside a platform bridging human and veterinary health research.
A current focus area is rare mitochondrial disease in children, supported by pharmaceutical partnerships and over £2 million in grant and angel funding.
Company Notes
Member of